Targeting transforming growth factor-β signaling in aortopathies in Marfan syndrome.

نویسندگان

  • Daigo Sawaki
  • Toru Suzuki
چکیده

topathy, with initial experiments showing prevention of aortic root expansion in a mouse model of MFS using RAS blockade,3 which was followed by studies in human patients that showed similar results.4,5 These findings were welcomed with enthusiasm as a pharmacological solution for MFS, and have prompted several human clinical trials, which are presently ongoing to determine the possible benefit of RAS blockade in aortopathy in MFS patients.6 TGFβ signaling has also received attention as a key factor in the aortopathy of MFS patients, as not only the canonical regulatory pathway involving downstream Smad proteins but also a non-canonical pathway involving ERK and JNK kinases has been recently described as implicated in MFS pathology upon activation of the TGFβ pathway.7,8 Moreover, circulating levels of TGFβ have received attention because they are not only elevated in patients with MFS aortopathy but are also responsive to pharmacological treatment, thus suggesting their possible use as a surarfan syndrome (MFS) is characterized by mutations in the fibrillin-1 gene and dysregulation of transforming growth factor-β (TGFβ) signaling, which is phenotypically associated with gradual weakening of connective tissue throughout the body, including the lungs, bones and cardiovascular system.1 A primary cause of mortality in MFS patients reaching adolescence or adulthood is aortic rupture or dissection. Surgery is generally performed to remove the affected portion of the aorta, but more than half of patients who have had their aortas repaired require additional surgery or manifest aortic rupture because of expansion of the unrepaired regions of the aorta over time.2 At present, measures to identify patients exhibiting progressive expansion or re-expansion of the aorta after surgery is a topic of importance. On medical therapy, β-blockers have been historically used as the anchoring agent. The renin-angiotensin system (RAS) has also recently been implicated in the pathogenesis of Marfan aorM

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Quantitative analysis of TGFBR2 mutations in Marfan-syndrome-related disorders suggests a correlation between phenotypic severity and Smad signaling activity.

Mutations in the gene encoding transforming growth factor-beta receptor type II (TGFBR2) have been described in patients with Loeys-Dietz syndrome (LDS), Marfan syndrome type 2 (MFS2) and familial thoracic aortic aneurysms and dissections (TAAD). Here, we present a comprehensive and quantitative analysis of TGFBR2 expression, turnover and TGF-β-induced Smad and ERK signaling activity for nine m...

متن کامل

Directed Blocking of TGF-β Receptor I Binding Site Using Tailored Peptide Segments to Inhibit its Signaling Pathway

Background: TGF-β isoforms play crucial roles in diverse cellular processes. Therefore, targeting and inhibiting TGF-β signaling pathway provides a potential therapeutic opportunity. TGF-β isoforms bind and bring the receptors (TβRII and TβRI) together to form a signaling complex in an ordered manner. Objectives: Herein, an antagonistic variant of TGF-β (AnTβ)...

متن کامل

Transforming Growth Factor‐β in Thoracic Aortic Aneurysms: Good, Bad, or Irrelevant?

M arfan syndrome is a multisystem disorder, but its most devastating manifestations are aortic aneurysms and dissection. This syndrome results from mutations in FBN1, which encodes fibrillin-1, a microfibrillar protein that decorates the surface of elastin fibers. Over 100 known mutations in FBN1 cause Marfan syndrome, resulting in a wide variance of clinical presentations in affected individua...

متن کامل

Marfan syndrome: from gene to therapy.

PURPOSE OF REVIEW Although historically Marfan syndrome (MFS) has always been considered as a condition caused by the deficiency of a structural extracellular matrix protein, fibrillin-1, the study of Marfan mouse models and Marfan-related conditions has shifted our current understanding to a pathogenic model that involves dysregulation of the cytokine-transforming growth factor beta (TGF-β) si...

متن کامل

Bone matrix to growth factors: location, location, location

The demonstration that fibrillin-1 mutations perturb transforming growth factor (TGF)-β bioavailability/signaling in Marfan syndrome (MFS) changed the view of the extracellular matrix as a passive structural support to a dynamic modulator of cell behavior. In this issue, Nistala et al. (2010. J. Cell Biol. doi: 10.1083/jcb.201003089) advance this concept by demonstrating how fibrillin-1 and -2 ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Circulation journal : official journal of the Japanese Circulation Society

دوره 77 4  شماره 

صفحات  -

تاریخ انتشار 2013